Jailendra Singh
Stock Analyst at Truist Financial
(0.18)
# 4,395
Out of 4,534 analysts
748
Total ratings
43.8%
Success rate
-5.8%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HIMS Hims & Hers Health | Reiterated: Hold | n/a | $32.70 | - | 57 | Jul 9, 2026 | |
| MDLN Medline | Maintained: Buy | n/a | $38.88 | - | 6 | Jul 9, 2026 | |
| TDOC Teladoc Health | Maintained: Hold | n/a | $9.65 | - | 62 | Jul 2, 2026 | |
| ASTH Astrana Health | Maintained: Buy | n/a | $44.55 | - | 29 | Jul 2, 2026 | |
| ICLR ICON Public Limited Company | Upgraded: Buy | $207 | $166.18 | +24.56% | 35 | Jun 30, 2026 | |
| EVH Evolent Health | Downgraded: Hold | $7 | $5.93 | +18.04% | 52 | Jun 30, 2026 | |
| IQV IQVIA Holdings | Maintained: Buy | n/a | $203.90 | - | 46 | Jun 29, 2026 | |
| FTRE Fortrea Holdings | Maintained: Buy | n/a | $17.73 | - | 12 | Jun 29, 2026 | |
| GDRX GoodRx Holdings | Maintained: Hold | n/a | $3.14 | - | 40 | Jun 23, 2026 | |
| PGNY Progyny | Reiterated: Buy | $30 → $33 | $31.77 | +3.87% | 45 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $10.68 | - | 26 | Jun 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 | $87.70 | -3.08% | 22 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7.5 | $12.58 | -40.38% | 36 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $26.26 | +25.67% | 37 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $262 | $197.41 | +32.72% | 35 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $10.44 | - | 1 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $67 | $122.10 | -45.13% | 33 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 | $21.73 | -12.56% | 28 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.49 | - | 1 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $22.09 | - | 13 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $539 → $462 | $527.93 | -12.49% | 17 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $116 | $180.39 | -35.69% | 2 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.78 | - | 3 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $6.61 | - | 1 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $13.50 | n/a | 1 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $65.84 | n/a | 1 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $283.94 | n/a | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $382.23 | n/a | 1 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $50.66 | n/a | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.42 | n/a | 1 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $398.20 | n/a | 1 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $9.69 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.62 | n/a | 1 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1,146.90 | n/a | 1 | Jul 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $370.42 | n/a | 1 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $22 | $41.15 | n/a | 2 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $610 | $421.55 | n/a | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $23 → $19 | $0.31 | n/a | 11 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $31 → $16 | $1.42 | n/a | 19 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $42 → $43 | $3.32 | n/a | 12 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 → $24 | $0.7204 | n/a | 3 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $4 | $0.7117 | n/a | 9 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 → $180 | $303.99 | n/a | 14 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $50 → $62 | $225.75 | n/a | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $230 → $333 | $831.46 | n/a | 12 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $9 → $3.5 | $4.50 | n/a | 4 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $21 | $29.60 | n/a | 4 | Nov 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $137.72 | n/a | 1 | Feb 26, 2020 |
Hims & Hers Health
Jul 9, 2026
Reiterated: Hold
Price Target: n/a
Current: $32.70
Upside: -
Medline
Jul 9, 2026
Maintained: Buy
Price Target: n/a
Current: $38.88
Upside: -
Teladoc Health
Jul 2, 2026
Maintained: Hold
Price Target: n/a
Current: $9.65
Upside: -
Astrana Health
Jul 2, 2026
Maintained: Buy
Price Target: n/a
Current: $44.55
Upside: -
ICON Public Limited Company
Jun 30, 2026
Upgraded: Buy
Price Target: $207
Current: $166.18
Upside: +24.56%
Evolent Health
Jun 30, 2026
Downgraded: Hold
Price Target: $7
Current: $5.93
Upside: +18.04%
IQVIA Holdings
Jun 29, 2026
Maintained: Buy
Price Target: n/a
Current: $203.90
Upside: -
Fortrea Holdings
Jun 29, 2026
Maintained: Buy
Price Target: n/a
Current: $17.73
Upside: -
GoodRx Holdings
Jun 23, 2026
Maintained: Hold
Price Target: n/a
Current: $3.14
Upside: -
Progyny
Jun 22, 2026
Reiterated: Buy
Price Target: $30 → $33
Current: $31.77
Upside: +3.87%
Jun 12, 2026
Maintained: Hold
Price Target: n/a
Current: $10.68
Upside: -
Jun 11, 2026
Reiterated: Buy
Price Target: $85
Current: $87.70
Upside: -3.08%
Jun 8, 2026
Maintained: Hold
Price Target: $7.5
Current: $12.58
Upside: -40.38%
Jun 8, 2026
Maintained: Buy
Price Target: $33
Current: $26.26
Upside: +25.67%
Jun 4, 2026
Maintained: Buy
Price Target: $262
Current: $197.41
Upside: +32.72%
Jun 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $10.44
Upside: -
May 18, 2026
Reiterated: Hold
Price Target: $67
Current: $122.10
Upside: -45.13%
May 18, 2026
Maintained: Hold
Price Target: $19
Current: $21.73
Upside: -12.56%
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $2.49
Upside: -
Apr 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $22.09
Upside: -
Apr 24, 2026
Reiterated: Hold
Price Target: $539 → $462
Current: $527.93
Upside: -12.49%
Feb 27, 2026
Reiterated: Buy
Price Target: $116
Current: $180.39
Upside: -35.69%
Sep 4, 2025
Maintained: Buy
Price Target: n/a
Current: $7.78
Upside: -
Jul 30, 2025
Maintained: Hold
Price Target: n/a
Current: $6.61
Upside: -
Jul 17, 2025
Maintained: Buy
Price Target: n/a
Current: $13.50
Upside: n/a
Jul 2, 2025
Maintained: Buy
Price Target: n/a
Current: $65.84
Upside: n/a
May 5, 2025
Reiterated: Buy
Price Target: n/a
Current: $283.94
Upside: n/a
Apr 21, 2025
Reiterated: Buy
Price Target: n/a
Current: $382.23
Upside: n/a
Jan 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $50.66
Upside: n/a
Nov 19, 2024
Maintained: Buy
Price Target: n/a
Current: $1.42
Upside: n/a
Oct 3, 2024
Rated: Hold
Price Target: n/a
Current: $398.20
Upside: n/a
Sep 9, 2024
Maintained: Hold
Price Target: n/a
Current: $9.69
Upside: n/a
Sep 4, 2024
Reiterated: Buy
Price Target: n/a
Current: $1.62
Upside: n/a
Jul 3, 2024
Maintained: Buy
Price Target: n/a
Current: $1,146.90
Upside: n/a
Apr 29, 2024
Reiterated: Buy
Price Target: n/a
Current: $370.42
Upside: n/a
Apr 16, 2024
Maintained: Hold
Price Target: $21 → $22
Current: $41.15
Upside: n/a
Nov 29, 2022
Reiterated: Buy
Price Target: $610
Current: $421.55
Upside: n/a
Aug 16, 2022
Maintained: Hold
Price Target: $23 → $19
Current: $0.31
Upside: n/a
Mar 3, 2022
Maintained: Hold
Price Target: $31 → $16
Current: $1.42
Upside: n/a
Feb 28, 2022
Maintained: Hold
Price Target: $42 → $43
Current: $3.32
Upside: n/a
Feb 24, 2022
Maintained: Hold
Price Target: $30 → $24
Current: $0.7204
Upside: n/a
Feb 8, 2022
Downgraded: Hold
Price Target: $14 → $4
Current: $0.7117
Upside: n/a
Jan 7, 2022
Maintained: Buy
Price Target: $145 → $180
Current: $303.99
Upside: n/a
Jan 7, 2022
Maintained: Hold
Price Target: $50 → $62
Current: $225.75
Upside: n/a
Jan 7, 2022
Upgraded: Buy
Price Target: $230 → $333
Current: $831.46
Upside: n/a
Jan 7, 2022
Downgraded: Sell
Price Target: $9 → $3.5
Current: $4.50
Upside: n/a
Nov 11, 2021
Maintained: Buy
Price Target: $26 → $21
Current: $29.60
Upside: n/a
Feb 26, 2020
Maintained: Buy
Price Target: $30
Current: $137.72
Upside: n/a